期刊文献+

外周血淋巴细胞监测人类免疫缺陷病毒和获得性免疫缺陷综合症疗效评价 被引量:2

Changes in Total Lymphocyte Count as a Surrogate in Monitoring HIV/AIDS Patients
原文传递
导出
摘要 目的研究人类免疫缺陷病毒(HIV)感染者和获得性免疫缺陷综合症(AIDS)患者CD4+T淋巴细胞数变化(ΔCD4+T)和外周血淋巴细胞总数变化(ΔTLC)的相关性。探讨用ΔTLC预测ΔCD4+T在监测HIV/AIDS患者疾病进展以及高效抗逆转录病毒治疗(HAART)疗效的价值。方法回顾性分析20052008年确诊的91例HIV/AIDS患者的临床资料。结果ΔTLC与ΔCD4+T呈直线正相关(r=0.809,P<0.01),好于TLC与CD4+T的相关性(r=0.712,P<0.01)。分别用ΔTLC170、330、630、910个/μL细胞预测ΔCD4+T50、100、200、300个/μL细胞时具有较好的预测价值,各项评价指标符合率基本达到90%以上,显著高于相同时间下用TLC预测CD4+T计数的价值。结论应用ΔTLC预测ΔCD4+T,可比TLC更加直观、准确的反映HIV感染者疾病进展和评价AIDS患者HAART的疗效。 Objective To assess the utility of total lymphocyte count(TLC)changes(ΔTLC)in place of TLC to predict the development of HIV/AIDS.To investigate the monitoring value of ΔCD4^+T on progress of HIV/AIDS and HAART which predicted by ΔTLC.Methods Clinical data of 91 patiens with HIV/AIDS diagnosed from 2005 to 2009 were retrospectively analyzed.Results A linear correlation was found between the value of ΔTLC and the value of CD4^+T changes(ΔCD4^+T)(r=0.809,P〈0.01),which was better than the correlation between TLC and CD4^+T(r=0.712,P〈0.01).Using ΔTLC as 170,330,630,910 cells/μL,respectively for forecasting ΔCD4^+T as 50,100,200,300 cells/μL,respectively,had a better predictive value with the area under ROC curve near to 0.9,significantly higher than using TLC for predicting CD4^+T counts.Conclusion ΔTLC is more accurate than TLC to reflect the development of HIV/AIDS.
出处 《华西医学》 CAS 2010年第4期697-699,共3页 West China Medical Journal
关键词 人类免疫缺陷病毒 获得性免疫缺陷综合症 CD4^+T淋巴细胞计数 淋巴细胞总数 Human immunodeficiency virus Acquired immune deficiency syndrome CD4^+T lymphocyte count Total lymphocyte count
  • 相关文献

参考文献10

二级参考文献54

  • 1张福杰,郜桂菊,赵红心,宋映雪,姚均,韩宁,卢联合,李鑫.HIV/AIDS患者中CD_4细胞计数与总淋巴细胞计数间相关性研究[J].中国艾滋病性病,2004,10(4):241-243. 被引量:30
  • 2姚文虎,赵伟,赵红,魏洪霞,成骢,潘淮宁.高效抗逆转录病毒治疗艾滋病的临床研究[J].江苏医药,2004,30(10):772-773. 被引量:19
  • 3姚文虎,赵伟,赵红,魏洪霞.AIDS合并卡氏肺孢子虫肺炎8例报告[J].中国艾滋病性病,2004,10(5):383-384. 被引量:12
  • 4陈铁龙,桂希恩,邓莉萍,Caroline Teter,孙静.湖北成人CD_4、CD_8T淋巴细胞计数正常值调查及CD_4与总淋巴细胞数的相关性分析[J].中国艾滋病性病,2005,11(4):252-254. 被引量:35
  • 5N. Kumarasamy,Anish P.Mahajan,et al Total lymphacyte count Is aUseful Tool for the Timing of Opportunisitic infection Prophylaxis in india and Other Resourse-constrained Countries[J] .AIDS Journal of Acquired Immune Deficiency Syndromes2002 ;31:378-383.
  • 6Wiktor SZ Morokro MS ,GrantAD ,et al .efficacy of trimethoprin-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1infected patients with tuberculosis in Abidjan, Cote d'Ivoire:a randomised control trial[J]. Lancet,1999,353:1469-1474
  • 7Dayton JM, Merson MH Global dimensions of the AIDS epidemic: Implications for prevention and care[J].Infect Dis Clin North Am,2000,14:4.
  • 8Badri M ,EhrlichR ,Wood R,et al Initiating cotriimoxazole prophylaxis in HIV-infected patients in Africa:an evaluation of the provisional WHO/UNAIDS recommendations[J]:AIDS, 2001,15:1143-1148.
  • 9Fournier AM, Sosenko JM. The relatiomship of total lymphacyte count to CD4 lymphacyte counts in patient infected with human immunodeficiency virus[J]. Am J Med Sci, 1992, 304: 79-82.
  • 10Blatt SP, Lucey CR, Butzin CA, et al. Total lymphacyte count as a predictor of absolute CD4 count and CD4% in HIV infected perected persons[J],JAMA, 1993, 269: 622-626

共引文献87

同被引文献17

  • 1L. Valor,J. Navarro,J. Carbone,C. Rodríguez-Sáinz,J. Gil,F. López,E. Fernández-Cruz.Immunization with an HIV-1 immunogen induces CD4 + and CD8 + HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy[J].Vaccine.2008(22)
  • 2Nattawat Onlamoon,Sutchana Tabprasit,Surapol Suwanagool,Suda Louisirirotchanakul,Aftab A. Ansari,Kovit Pattanapanyasat.Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand[J].Virology.2005(2)
  • 3Travis C Porco,Jeffrey N Martin,Kimberly A Page-Shafer,Amber Cheng,Edwin Charlebois,Robert M Grant,Dennis H Osmond.Decline in HIV infectivity following the introduction of highly active antiretroviral therapy[J].AIDS.2004(1)
  • 4Mary E. Paul,William T. Shearer,Claudia A. Kozinetz,Dorothy E. Lewis.Comparison of CD8 + T-cell subsets in HIV-infected rapid progressor children versus non–rapid progressor children[J].The Journal of Allergy and Clinical Immunology.2001(2)
  • 5Bruno Ledergerber,Matthias Egger,Milos Opravil,Amalio Telenti,Bernard Hirschel,Manuel Battegay,Pietro Vernazza,Philippe Sudre,Markus Flepp,Hansjakob Furrer,Patrick Francioli,Rainer Weber.Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study[J].The Lancet.1999(9156)
  • 6李群辉,高艳青,孙欣,刘意,叶江竹,计云霞,孙丽君,张可.HIV/AIDS病人高效抗逆转录病毒治疗效果的临床评价[J].中国艾滋病性病,2008,14(4):354-356. 被引量:38
  • 7周华英,郑煜煌,何艳,龚国忠,谌资,刘猛,尹伟,刘纯.高效抗逆转录病毒治疗艾滋病毒感染者和艾滋病患者的6年临床疗效及安全性观察[J].中南大学学报(医学版),2009,34(8):731-737. 被引量:18
  • 8张海君,李超,于保平,杨梦,杨雪玲,邢浩.CD_4+T淋巴细胞极低艾滋病30例临床分析[J].河南预防医学杂志,2010,21(2):99-100. 被引量:1
  • 9高莉,高良敏,杨增源,杨建华,赵余仙,杨炳丽,冯晓静,聂永英,王蓉,余顺俊,杨希,李燕,武学维,李洪.应用寿命表法估计HIV/AIDS患者的死亡概率和生存率[J].中国预防医学杂志,2010,11(6):551-553. 被引量:3
  • 10封小林,谭晓东,孙静,何卫华,周沛林,李少平,龚文胜,邱兴庆.HIV感染者抗病毒治疗后健康状况的调查[J].公共卫生与预防医学,2010,21(4):18-21. 被引量:3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部